Asklepios BioPharmaceutical Inc Email Format

BiotechnologyNorth Carolina, United States0-1 Employees

Asklepios BioPharmaceutical Inc., known as AskBio, is a privately held biotechnology company focused on developing protein and cellular therapies through its Biological Nano Particles (BNP) platform. The BNP technology aims to enable sustained, systemic delivery of therapeutic proteins by using the patient's own cells as bioreactors and pumps to produce and release the treatment. Founded in 2003 and based in Chapel Hill, North Carolina, the company operates as a small, clinical-stage enterprise. Its programs target neuromuscular and other indications, including AB-1009 for late-onset Pompe disease in a Phase 1/2 trial (PROGRESS-GT LOPD). In May 2026, the company dosed the first participant in this trial, reflecting progress in its clinical validation.

Sign up for free to view info

Company overview Employee directory